Antiaging Injection
Pharmaceutical form
Injectable solution intramuscular
Composition
Each ampoule contains:
Procaine hydrochloride 100 mg
Benzoic acid 6 mg
Disodium phosphate dodecahydrate 0.5 mg
Potassium metabisulfite 5 mg
Distilled water for injectable solutions up to 5 ml
DETAILS
Pharmaceutical form
Injectable solution intramuscular
Composition
Each ampoule contains: Procaine hydrochloride 100 mg
Benzoic acid 6 mg
Disodium phosphate dodecahydrate 0.5 mg
Potassium metabisulfite 5 mg
Distilled water for injectable solutions up to 5 ml
Pharmacotherapeutic Group
Alimentary track and metabolism
Therapeutic indications
Protection of the organism against aging phenomena
Depressive syndrome (light and moderate depression), in precocious stages, specially when conventional therapy in not welltolerated or it has contraindications. Parkinsonian syndromes where it can be used in monotherapy or associated with other antiparkinsonian drugs, especially with dopaminergic agents. Osteoarthritis (chronic degenerative rheumatism) Systemic arteriosclerosis with hypercholesterolemia, ischaemic, heart disease, arteritis, cerebral atherosclerosis.
ContraindicationsHypersensitivity to procaine in antecedents or tested. Severe arterial hypotension. Associated treatment with sulfonamides (except the antidiabetic ones) and with acetlylcholinesterase agents, neostygmine, serine (physostigmine) and pyridostigmine.
Precautions regarding medicinal product administrationBefore starting the treatment, a test for individual tolerance to procaine should be made (see under Posology and method of administration). The treatment must take place under medical supervision, mainly in the first series of treatment, in order to establish the optimal dose. The product should be administered with caution in patients with orthostatic hypotension. Although procaine medication is not carcinogenic, it is not recommended to the patients with cancer, as its simulating effect on mitotic potential of the neoplastic cell is not excluded.
Interactions with other medicinal products or ther substancesAntiaging injection should not be administered simultaneously with su1phonamides (antagonistic mechanism of action) except the antidiabetic ones, anticholisnesterases: neostygmine, serine (physostigmine) and pyridostigmine. Special warnings Pregnant and breastfeeding women: The studies on animals did not show teratogenic effects. In absence of teratogenic effects on animals, malformative effects on humans are not expected. However, the clinical experience with Antiaging Injection is mainly on patients over the procreation period. For these reasons we do not recommend the use of the product during pregnancy lactation. Potential effect on the ability to drive or to use machines: The product does not interfere with these abilities.
Posology and method of adminisrationBefore starting the treatment with Antiaging Injection ,it is compulsory to test individual sensitivity to procaine, as follows: 1 ml from the injectable solution of Antiaging Injection will be administered subcutaneously and after 24 hours the test should be repeated with 1.5 ml solution intramuscularly. If any allergic reaction occurs, the treatment is not recommended. For protection of the organism against aging phenomena (standard schedule), alternative courses of injections and tables of Antiaging Injection should be administered, as follows: Injectable solution: 1 intramuscular injection, 3 times a week (one ampoule every other day), over a period of 4 weeks (12 ampoules). Sugar coated tablets: 2 sugarcoated tablets/day, after meals, in the morning and in the afternoon, for 12 days. Series of injections and sugarcoated tablets should be alternated yearly, continuously or with one month pause between them. The schedule and the frequency of pauses will be decided by the geriatrist, according with the aging status of the patient.
Curative treatmentDepressive syndrome: 1st week: 1 ampoule i.m/day, 3 times a week (i.e., on Monday, on Wednesday and on Friday); 2nd and 3_rd week: 1 ?ampoules i.m., 3 times a week; 4th week; 2 ampoules i.m., 3 times a week The treatment should be repeated 46 times a year.
Parkinsonian syndromesDaily administration of 1 ampoule i.m. and two sugarcoated tablets, for 15 days.
Osteoarthritis1 ampoule i.m./day, for 1521 days and then 1 ampoule i.m. 3 times a week (every other day), for 4 weeks, repeated of 45 times/year. During the pauses in injections series, 12 sugarcoated tablets/day, 1218 days/month, can be administrated.
Systemic arteriosclerosisDepending of the intensity and the localization of the process, the treatment should be as follows: 1 ampoule i.m./day, 3 times a week, 4 week (12 ampoules), repeated 56 times/year. Between the injections series, oral treatment may be added 2 sugarcoated tablets/day, 12 days. In some cases the treatment can be exclusively oral: 3 sugarcoated tablets/day, 21 days in 68 series/year.
Adverse reactions, which can occur during teh use of the medicinal productAdministration of Antiaging Injection may produce allergic reactions in patients with hypersensitivity to procaine like skin rash or pruritus. These effects impose an immediate stop of the treatment. Minor effects may occur especially at the beginning of the treatment like: dizziness, weakness and palpitations. These effects can be avoided if after the injections the patient rests in bed for 1015 minutes.
OverdoseThere are no reports of overdose related to administration of Antiaging Injection. In case of accidentally injection of high doses, severe hypotension, convulsions, coma, respiratory arrest may occur. The treatment is symptomatic and support of vital functions.
StorageStore below 25°C. Keep out the reach of children. Do not use after the expiry date printed on the package.
Reviews
There are no reviews yet.